Trial Profile

Phase 2 clinical trial in patients with asthma

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 06 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs APG 777 (Primary)
Indications Asthma
Focus Adverse reactions; Therapeutic Use
Sponsors Apogee Therapeutics

Most Recent Events

03 Mar 2025 According to an Apogee Therapeutics media release, data expected in 2026.
03 Feb 2025 According to an Apogee Therapeutics media release, company anticipates initiating this Phase 2b trial in asthma in the second half of 2025
06 Mar 2024 According to an Apogee Therapeutics media release, company anticipates initiating a Phase 2 trial in asthma in 2025

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com